|
|
|
(Thousands of yen) |
Category |
2016/12 |
2017/12 |
2018/12 |
2019/12 |
Net sales |
2,455,738 |
1,818,402 |
1,518,630 |
1,227,482 |
Operating Income |
-622,920 |
-144,296 |
-198,095 |
-358,928 |
Ordinary Income |
-674,202 |
-233,862 |
-290,811 |
-435,568 |
Net Income |
-503,298 |
-216,306 |
-290,825 |
-1,081,295 |
Total Assets |
455,760 |
240,621 |
-55,430 |
-1,135,912 |
Sharholders' Equity |
4,031,933 |
2,876,764 |
2,454,145 |
1,217,798 |
Outstanding stock |
16,143,170shares |
16,143,170shares |
16,143,170shares |
16,143,170shares |
Book-value per Share |
28.23yen |
14.91yen |
-3.43yen |
-70.37yen |
Earning per Share |
-31.18yen |
-13.40yen |
-18.02yen |
-66.99yen |
Equity Ratio |
11.3% |
8.4% |
-2.3% |
-93.3% |
Return on Equity |
-71.1% |
-62.1% |
-314.1% |
| |
Cash flows from operating activities |
| |
| |
| |
-169,002 |
Cash flows from investing activties |
| |
| |
| |
354,025 |
Cash flows from financing activities |
| |
| |
| |
-200,190 |
Cash and cash equivalents at end of year |
| |
| |
| |
27,026 |
Capital Expenditure |
55,541 |
32,773 |
54,796 |
37,011 |
Depreciation |
253,283 |
127,839 |
100,911 |
93,414 |
Research and Development Cost |
15,000 |
| |
| |
7,915 |
Cash Dividends per Share |
| |
| |
| |
| |
Number of Employees |
185persons |
144persons |
125persons |
113persons |
|
|
|
|